...
首页> 外文期刊>Chemical and Pharmaceutical Bulletin >Immediate release tablets of telmisartan using superdisintegrant-formulation, evaluation and stability studies.
【24h】

Immediate release tablets of telmisartan using superdisintegrant-formulation, evaluation and stability studies.

机译:使用超崩解剂配方,评估和稳定性研究的替米沙坦速释片。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Telmisartan (anti-hypertensive) is insoluble in water; hence the drug may be slowly or incompletely dissolved in the gastro intestinal tract. So the rate of dissolution and therefore its bioavailability is less (bioavailability 42%). In the present study an attempt has been made to prepare immediate release tablets of telmisartan by using Polyplasdone XL-10 (Crosspovidone) at intragranular, extragranular and partly intra and extragranular level of addition to increase the rate of drug release from dosage form to increase the dissolution rate and hence its bioavailability. The prepared granules and tablets were evaluated for their physiochemical properties and in-vitro dissolution study was conducted for the prepared tablets. It was concluded that the immediate release tablets with proper hardness, disintegration time and with increase rate of dissolution can be made using Polyplasdone XL-10. Formuation-10 (F10) was selected for stability study and the in-vitro dissolution study showed that was no difference in percent of drug released between initial and sixth month sample.
机译:替米沙坦(抗高血压药)不溶于水;因此,药物可能会在胃肠道中缓慢或不完全溶解。因此,溶解速率及其生物利用率较低(生物利用率42%)。在本研究中,已经尝试通过在颗粒内,颗粒外以及部分和颗粒内和颗粒外的水平使用Polyplasdone XL-10(交叉维维酮)来制备替米沙坦的速释片剂,以增加药物从剂型中释放的速率,从而增加剂量。溶解速度及其生物利用度。评价制备的颗粒和片剂的理化性质,并对制备的片剂进行体外溶出研究。结论是可以使用Polyplasdone XL-10制成具有适当硬度,崩解时间和增加溶出速率的速释片剂。选择Formation-10(F10)进行稳定性研究,体外溶出研究表明,最初和第六个月的样品之间释放的药物百分比没有差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号